Percheron Therapeutics Limited
PERCF
$0.0025
-$0.0165-86.84%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -10.36M | -9.13M | -7.82M | -7.50M | -7.23M |
| Total Depreciation and Amortization | 45.00K | 48.60K | 52.00K | 57.30K | 63.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 184.40K | 157.80K | 130.90K | -782.20K | -1.71M |
| Change in Net Operating Assets | 1.00M | 1.00M | 1.00M | 1.48M | 1.99M |
| Cash from Operations | -9.13M | -7.92M | -6.64M | -6.74M | -6.89M |
| Capital Expenditure | -2.80K | -2.50K | -2.30K | -5.50K | -8.70K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -2.80K | -2.50K | -2.30K | -5.50K | -8.70K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -77.80K | -83.60K | -89.40K | -87.00K | -84.60K |
| Issuance of Common Stock | 14.87M | 13.24M | 11.61M | 11.61M | 11.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -756.00K | -629.60K | -503.20K | -547.50K | -591.80K |
| Cash from Financing | 9.28M | 8.29M | 7.20M | 7.17M | 7.14M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 142.60K | 372.20K | 560.70K | 426.70K | 245.30K |